Shareholders Equity and Capital Stock (Details 7) |
6 Months Ended |
|---|---|
|
Jun. 30, 2022
USD ($)
$ / shares
shares
| |
| Warrants | |
| Exercise Price | $ / shares | $ 1.17 |
| Number Of Warrants | shares | 23,850,530 |
| Remaining Contractual Life (years) | 1 year 2 months 12 days |
| Aggregate Intrinsic Value | $ | $ 1,103,600 |
| Exercise price $0.75 | |
| Exercise Price | $ / shares | $ 0.75 |
| Number Of Warrants | shares | 7,120,000 |
| Remaining Contractual Life (years) | 1 month 6 days |
| Aggregate Intrinsic Value | $ | $ 1,103,600 |
| Expiry | Aug. 04, 2022 |
| Exercise price $1.35 | |
| Exercise Price | $ / shares | $ 1.35 |
| Number Of Warrants | shares | 16,730,530 |
| Remaining Contractual Life (years) | 1 year 7 months 6 days |
| Aggregate Intrinsic Value | $ | $ 0 |
| Expiry | Feb. 04, 2024 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|